Oxazole compound and pharmaceutical composition
US8637559B2 · kind B2 · utility
1Cited by
3References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 14, 2006 |
| Grant date | Jan 28, 2014 |
| Priority date | — |
| Expiry date | Feb 9, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y301/04012
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a oxazole compound represented by Formula (1), or a salt thereof:wherein R1 is an aryl group which may have one or more substituents; R2 is an aryl group or a nitrogen atom-containing heterocyclic group each of which may have one or more substituents; and W is a divalent group represented by —Y1-A1- or —Y2—C(═O)— wherein Y1 is a group such as —C(═O)—, A1 is a group such as a lower alkylene group, and Y2 is a group such as a piperazinediyl group. The oxazole compound has a specific inhibitory action against phosphodiesterase 4.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.